Aviso: Este site agrega dados públicos oficiais da FDA, ClinicalTrials.gov, PubMed e SEC EDGAR apenas para referência geral. Não constitui aconselhamento médico, diagnóstico, recomendação de tratamento ou aconselhamento de investimento.

FDA PMA

Continuous glucose monitor, implanted, adjunctive use

Número do PMA: P160048 · 2026-03-19

RequerenteSenseonics, Incorporated
Data da decisão2026-03-19
Número PMAP160048
Código do produtoQCD
Classe do DispositivoClasse 3
Especialidade MédicaU
Comité consultivoCH

Resumo do dispositivo

Continuous glucose monitor, implanted, adjunctive use is the device name listed in this FDA 510(k) record. The listed applicant is Senseonics, Incorporated. It received FDA 510(k) clearance on 2026-03-19. The device is classified under product code QCD. It was reviewed by the CH advisory panel.

Perguntas frequentes

What is the Continuous glucose monitor, implanted, adjunctive use?

Continuous glucose monitor, implanted, adjunctive use is a medical device that received FDA 510(k) clearance on 2026-03-19. The listed applicant is Senseonics, Incorporated.

When did Continuous glucose monitor, implanted, adjunctive use receive FDA 510(k) clearance?

The clearance date for Continuous glucose monitor, implanted, adjunctive use can be found in the official FDA records.

Who is the listed applicant for Continuous glucose monitor, implanted, adjunctive use?

The FDA 510(k) record lists Senseonics, Incorporated as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Continuous glucose monitor, implanted, adjunctive use?

The FDA product code for Continuous glucose monitor, implanted, adjunctive use is QCD.

Ensaios clínicos relacionados

Registros relacionados são pareados automaticamente usando nomes, códigos de produtos ou outros metadados. Um pareamento não estabelece um vínculo clínico, científico, corporativo ou regulatório verificado; revise as fontes oficiais vinculadas.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Fonte oficial

Ver na base de dados da FDA →

Dados provenientes da FDA Open API. Para informações mais recentes e oficiais, consulte sempre o registro oficial.

↑